Issuer disclosure record

$HALO

Company name unavailable

Transactions involving this ticker in readable 2022 House reports. This page describes disclosure activity, not the issuer’s performance and not a recommendation to trade.

Purchases

Sales

Filers

Reports

Transaction history

Who disclosed trading $HALO?

Open in trade feed →

Partial saleRep. Josh GottheimerNJ-05

$HALOHalozyme Therapeutics, Inc. (HALO)

Rep. Josh Gottheimer's filing reports that a joint account partially sold · $1,001 – $15,000

View transaction source status →

Traded Aug 5, 2022Notified Sep 6, 2022Filed Sep 16, 202242 days to file

Owner: JointOriginal filing ↗